Boston Scientific (BSX -0.5%) slips into the red today, despite saying it's received CE Mark...

|About: Boston Scientific Corporation (BSX)|By:, SA News Editor

Boston Scientific (BSX -0.5%) slips into the red today, despite saying it's received CE Mark approval for the Promus Premier Everolimus-Eluting Platinum Chromium Coronary Stent System, and is initiating its European market launch. The system is designed to provide physicians improved drug eluting stent performance for treating patients with coronary artery disease.